☰

Rachel E. Johns, Ph.D. - Publications

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Seth S, Johns R, Templin MV. Delivery and biodistribution of siRNA for cancer therapy: challenges and future prospects. Therapeutic Delivery. 3: 245-61. PMID 22834200 DOI: 10.4155/Tde.11.155  0.378
2012 Liu Y, Chen Y, Fosnaugh K, Seth S, Matsui Y, Harvie P, Johns R, Takagi A, Vaidyanathan S, Severson G, Brown T, Zhu T, Charmley P, So A, Houston M, et al. Abstract 281: Novel nucleic acid constructs and formulations for treatment of bladder cancer and malignant ascites Cancer Research. 72: 281-281. DOI: 10.1158/1538-7445.Am2012-281  0.419
2011 Adami RC, Seth S, Harvie P, Johns R, Fam R, Fosnaugh K, Zhu T, Farber K, McCutcheon M, Goodman TT, Liu Y, Chen Y, Kwang E, Templin MV, Severson G, et al. An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1141-51. PMID 21505423 DOI: 10.1038/Mt.2011.56  0.372
2011 Seth S, Matsui Y, Fosnaugh K, Liu Y, Vaish N, Adami R, Harvie P, Johns R, Severson G, Brown T, Takagi A, Bell S, Chen Y, Chen F, Zhu T, et al. RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 928-35. PMID 21364537 DOI: 10.1038/Mt.2011.21  0.426
2011 Collie AM, Bota PC, Johns RE, Maier RV, Stayton PS. Differential monocyte/macrophage interleukin-1β production due to biomaterial topography requires the β2 integrin signaling pathway. Journal of Biomedical Materials Research. Part A. 96: 162-9. PMID 21105164 DOI: 10.1002/Jbm.A.32963  0.32
2011 Vaish N, Chen F, Seth S, Fosnaugh K, Liu Y, Adami R, Brown T, Chen Y, Harvie P, Johns R, Severson G, Granger B, Charmley P, Houston M, Templin MV, et al. Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs. Nucleic Acids Research. 39: 1823-32. PMID 21047800 DOI: 10.1093/Nar/Gkq961  0.367
2010 Fosnaugh KL, Seth S, Matsui Y, Adami R, Vaish N, Chen Y, Liu Y, Harvie P, Johns R, Severson G, Bell S, Granger B, Zhu T, Charmley P, So A, et al. Abstract 581: Development of RNA interference-based therapeutics for bladder cancer and hepatocellular carcinoma Cancer Research. 70: 581-581. DOI: 10.1158/1538-7445.Am10-581  0.375
2008 Johns RE, El-Sayed ME, Bulmus V, Cuschieri J, Maier R, Hoffman AS, Stayton PS. Mechanistic analysis of macrophage response to IRAK-1 gene knockdown by a smart polymer-antisense oligonucleotide therapeutic. Journal of Biomaterials Science. Polymer Edition. 19: 1333-46. PMID 18854126 DOI: 10.1163/156856208786052326  0.477
2004 Johns RE, Hoffman AS, Stayton PS. 639. Gene Expression Analysis of LPS Stimulated THP-1 Cells Treated with Antisense IRAK1 Delivered Using a pH-Sensitive, Membrane Disruptive Polymer Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.577  0.49
Show low-probability matches.